Barenie, Rachel E.
Gagne, Joshua J.
Kesselheim, Aaron S.
Pawar, Ajinkya
Tong, Angela
Luo, Jing
Bateman, Brian T.
Funding for this research was provided by:
Arnold Ventures
Article History
First Online: 16 March 2020
Compliance with Ethical Standards
:
: Rachel Barenie serves as a clinical consultant to Alosa Health for opioid use disorder and pain management-related work. Joshua Gagne has received salary support from grants from Eli Lilly and Company and Novartis Pharmaceuticals Corporation and was a consultant to Aetion, Inc, and Optum, Inc., all for unrelated work. Aaron Kesselheim reports serving as an expert witness for the class of state plaintiffs in the multidistrict opiate litigation (2018–2019). Jing Luo has served as a clinical consultant to Alosa Health for opioid use disorder and pain management-related work. Jing Luo is now an Assistant Professor of Medicine at the University of Pittsburgh in Pittsburgh, PA and receives research support from the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR001856. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. Brian Bateman serves as a consultant to Alosa Health for opioid use disorder and pain management-related work and Aetion, Inc and Merck for Mothers for unrelated work. Brian Bateman is a co-investigator on grants to his institution from Eli Lilly, GSK, Pfizer, Pacira, and Baxalta. Ajinkya Pawar and Angela Tong have no conflicts of interest that are directly relevant to the content of this study.
: The Brigham and Women’s Hospital waived the need for informed consent for this study.
: Not applicable.